These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28590545)

  • 21. Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis.
    Burns TM; Conaway MR; Cutter GR; Sanders DB;
    Muscle Nerve; 2008 Aug; 38(2):957-63. PubMed ID: 18642357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developing outcome measures of disease activity in pediatric myasthenia.
    Prior DE; Cooper BA; Zhang B; Ghosh PS
    Muscle Nerve; 2021 May; 63(5):751-757. PubMed ID: 33604899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tongue force in patients with myasthenia gravis.
    Weijnen FG; Kuks JB; van der Bilt A; van der Glas HW; Wassenberg MW; Bosman F
    Acta Neurol Scand; 2000 Nov; 102(5):303-8. PubMed ID: 11083507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consideration of repetitive nerve stimulation of the median nerve in patients being evaluated for myasthenia gravis.
    Lee TH; Li Y
    Muscle Nerve; 2019 Dec; 60(6):658-661. PubMed ID: 31531870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translation, cross-cultural adaptation, and validation of the french version of the 15-item Myasthenia Gravis Quality Of life scale.
    Birnbaum S; Ghout I; Demeret S; Bolgert F; Eymard B; Sharshar T; Portero P; Hogrel JY
    Muscle Nerve; 2017 May; 55(5):639-645. PubMed ID: 27533497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with ocular symptoms referred for electrodiagnosis: how many of them suffer from myasthenia gravis?
    Zambelis T; Pappas V; Kokotis P; Zouvelou V; Karandreas N
    Acta Neurol Belg; 2015 Dec; 115(4):671-4. PubMed ID: 25822064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translation and validation of the 15-item Myasthenia Gravis Quality of life scale in Dutch.
    Strijbos E; Gärtner FR; Verschuuren JJ
    Muscle Nerve; 2018 Feb; 57(2):206-211. PubMed ID: 28271514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of a single simple question in the evaluation of patients with nondiabetic polyneuropathy.
    Abraham A; Lovblom LE; Bril V
    Muscle Nerve; 2020 Apr; 61(4):526-529. PubMed ID: 31899544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of quality of life in Brazilian patients with myasthenia gravis.
    Mourão AM; Gomez RS; Barbosa LS; Freitas Dda S; Comini-Frota ER; Kummer A; Lemos SM; Teixeira AL
    Clinics (Sao Paulo); 2016 Jul; 71(7):370-4. PubMed ID: 27464292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construct and concurrent validation of the MG-QOL15 in the practice setting.
    Burns TM; Grouse CK; Conaway MR; Sanders DB;
    Muscle Nerve; 2010 Feb; 41(2):219-26. PubMed ID: 19941339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between regional myasthenic weakness and mental aspects of quality of life.
    Rostedt A; Padua L; Stålberg EV
    Eur J Neurol; 2006 Feb; 13(2):191-3. PubMed ID: 16490052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenia gravis: sleep quality, quality of life, and disease severity.
    Martínez-Lapiscina EH; Erro ME; Ayuso T; Jericó I
    Muscle Nerve; 2012 Aug; 46(2):174-80. PubMed ID: 22806365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myasthenia gravis: a quantitative evaluation system. Disability status scale (DSS) applied for myasthenia gravis.
    Szobor A
    Eur Neurol; 1976; 14(6):439-46. PubMed ID: 991881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extraocular muscle responses to orbital cooling (ice test) for ocular myasthenia gravis diagnosis.
    Ellis FD; Hoyt CS; Ellis FJ; Jeffery AR; Sondhi N
    J AAPOS; 2000 Oct; 4(5):271-81. PubMed ID: 11040476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Juvenile myasthenia gravis: three case reports and a literature review.
    Gadient P; Bolton J; Puri V
    J Child Neurol; 2009 May; 24(5):584-90. PubMed ID: 19406758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between a patient-derived functional questionnaire and abnormal neuromuscular transmission in Myasthenia Gravis patients.
    Rostedt A; Padua L; Stålberg EV
    Clin Neurophysiol; 2005 Sep; 116(9):2058-64. PubMed ID: 16043394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telephone consultation for myasthenia gravis care during the COVID-19 pandemic: Assessment of a novel virtual myasthenia gravis index.
    Menon D; Alnajjar S; Barnett C; Vijayan J; Katzberg H; Fathi D; Alcantara M; Bril V
    Muscle Nerve; 2021 Jun; 63(6):831-836. PubMed ID: 33792967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An update on myasthenia gravis].
    Martínez Torre S; Gómez Molinero I; Martínez Girón R
    Semergen; 2018; 44(5):351-354. PubMed ID: 29555378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscle strength and psychiatric symptoms influence health-related quality of life in patients with myasthenia gravis.
    Braz NFT; Rocha NP; Vieira ÉLM; Barbosa IG; Gomez RS; Kakehasi AM; Teixeira AL
    J Clin Neurosci; 2018 Apr; 50():41-44. PubMed ID: 29396072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.